Authors:
ROUGIER P
PAILLOT B
LAPLANCHE A
MORVAN F
SEITZ JF
REKACEWICZ C
LAPLAIGE P
JACOB J
GRANDJOUAN S
TIGAUD JM
FABRI MC
LUBOINSKI M
DUCREUX M
Citation: P. Rougier et al., 5-FLUOROURACIL (5-FU) CONTINUOUS INTRAVENOUS-INFUSION COMPARED WITH BOLUS ADMINISTRATION - FINAL RESULTS OF A RANDOMIZED TRIAL IN METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(11), 1997, pp. 1789-1793
Authors:
ROUGIER P
VANPOTTELSBERGHE C
KOK T
PAILLOT B
WAGENER T
DEGREVE J
FABRI MC
GERARD B
VANGLABBEKE M
BLEIBERG H
Citation: P. Rougier et al., FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP), European journal of cancer, 32A(8), 1996, pp. 1432-1433
Authors:
DUCREUX M
ROUGIER P
FANDI A
FANDI L
FABRI MC
ZARBA J
ARMAND JP
Citation: M. Ducreux et al., DEMONSTRATED EFFICIENCY OF 5-FLUOROURACIL (5FU) CONTINUOUS-INFUSION (CI) AND CISPLATIN (P) IN PATIENTS WITH ADVANCED BILIARY-TRACT CARCINOMA, European journal of cancer, 31A, 1995, pp. 554-554
Authors:
YAKENDJI K
ROUGIER P
DUCREUX M
DUVILLARD P
FABRI MC
LASSER P
ARMAND JP
Citation: K. Yakendji et al., EFFICACY OF THE COMBINATION OF ETOPOSIDE (E) AND CISPLATINUM (P) IN THE TREATMENT OF NEUROENDOCRIN DIGESTIVE CARCINOMA (NEC), European journal of cancer, 31A, 1995, pp. 563-563